Aburaihan Pharmaceutical Company (DABUR) financial ratios
Every ratio computed for this symbol, period by period, beside its industry and its own board
- Ticker
- DABUR
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | Report to 1404/12/29 | Report to 1403/12/30 | Report to 1402/12/29 | Report to 1401/12/29 |
|---|---|---|---|---|
| P/E TTM | 6.57 | 13.30 | 11.94 | 8.81 |
| P/S TTM | 2.14 | 1.79 | 1.57 | 2.77 |
| P/B | 5.00 | 6.28 | 5.13 | 5.98 |
| Gross margin TTM | 53.1% | 39.4% | 40.3% | 49.4% |
| Net margin TTM | 32.5% | 13.4% | 13.1% | 31.4% |
| ROA TTM | 32.4% | 9.7% | 8.7% | 24.8% |
| ROE TTM | 76.0% | 47.2% | 43.0% | 67.8% |
| Collection period TTM | 209 days | 356 days | 389 days | 281 days |
| Inventory period TTM | 128 days | 141 days | 143 days | 137 days |
| PEG TTM | 0.03 | 1.18 | - | 0.22 |
| PEGY TTM | 0.03 | 0.88 | - | 0.17 |